HilleVax, Inc. (HLVX) - Stock Prices, Stock Peers & Analysis

Home
HLVX

Company Name	HilleVax, Inc.
Symbol	HLVX
Currency	USD
Price	1.87
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	93,763,790
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.34 - 15.6
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Robert M. Hershberg M.D., Ph.D.
Website	https://www.hillevax.com

An error occurred while fetching data.

About HilleVax, Inc.

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.